Stay updated on Nemtabrutinib in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemtabrutinib in Hematologic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-14T02:54:55.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a centralized Locations section with state listings for study sites (Arizona, California, Colorado, Michigan, Minnesota, North Carolina, Ohio, Tennessee, Texas, Utah) and removed the old per-location pages for these states. Updated the revision to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T10:17:24.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1. No content or study data changes are included.
    Difference
    0.0%
    Check dated 2025-12-01T16:57:55.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The Publications section now clarifies that entries are provided voluntarily by the data submitter and may be auto-filled from PubMed. The revision note records v3.3.1, replacing the previous v3.2.0 wording.
    Difference
    0.1%
    Check dated 2025-11-24T13:36:02.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The site-wide notice about potential delays due to a lapse in government funding at the top of the ClinicalTrials.gov page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:34:18.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The update appears to be minor UI adjustments and an updated timestamp, with core study details, eligibility criteria, dosing, endpoints, and locations unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:12:54.000Z thumbnail image

Stay in the know with updates to Nemtabrutinib in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.